全文获取类型
收费全文 | 4658篇 |
免费 | 307篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 32篇 |
儿科学 | 183篇 |
妇产科学 | 95篇 |
基础医学 | 776篇 |
口腔科学 | 63篇 |
临床医学 | 331篇 |
内科学 | 850篇 |
皮肤病学 | 67篇 |
神经病学 | 324篇 |
特种医学 | 81篇 |
外科学 | 504篇 |
综合类 | 120篇 |
现状与发展 | 1篇 |
一般理论 | 4篇 |
预防医学 | 392篇 |
眼科学 | 155篇 |
药学 | 533篇 |
中国医学 | 73篇 |
肿瘤学 | 404篇 |
出版年
2023年 | 37篇 |
2022年 | 89篇 |
2021年 | 118篇 |
2020年 | 80篇 |
2019年 | 109篇 |
2018年 | 133篇 |
2017年 | 87篇 |
2016年 | 106篇 |
2015年 | 137篇 |
2014年 | 171篇 |
2013年 | 257篇 |
2012年 | 333篇 |
2011年 | 356篇 |
2010年 | 213篇 |
2009年 | 151篇 |
2008年 | 254篇 |
2007年 | 239篇 |
2006年 | 281篇 |
2005年 | 222篇 |
2004年 | 184篇 |
2003年 | 143篇 |
2002年 | 152篇 |
2001年 | 99篇 |
2000年 | 101篇 |
1999年 | 63篇 |
1998年 | 41篇 |
1997年 | 27篇 |
1996年 | 16篇 |
1995年 | 17篇 |
1994年 | 17篇 |
1993年 | 16篇 |
1992年 | 55篇 |
1991年 | 54篇 |
1990年 | 49篇 |
1989年 | 57篇 |
1988年 | 39篇 |
1987年 | 32篇 |
1986年 | 30篇 |
1985年 | 39篇 |
1984年 | 28篇 |
1983年 | 32篇 |
1981年 | 15篇 |
1980年 | 22篇 |
1979年 | 33篇 |
1978年 | 17篇 |
1977年 | 22篇 |
1976年 | 15篇 |
1974年 | 17篇 |
1973年 | 18篇 |
1972年 | 15篇 |
排序方式: 共有4988条查询结果,搜索用时 15 毫秒
101.
Orna Tzischinsky Itzhak Pal Rachel Epstein Yaron Dagan Peretz Lavie 《Journal of pineal research》1992,12(3):105-108
An 18-year-old blind man suffered from chronic sleep disturbances associated with daytime fatigue and excessive daytime somnolence. After two unsuccessful treatment regimens with 5 mg and 10 mg melatonin administered at bedtime (2200-2230), a third regimen of 5 mg melatonin administered at 2000 for 3 weeks resulted in a successful resolution of his sleep disturbances. We suggest that the efficacy of melatonin in ameliorating sleep disturbances because of alterations in circadian rhythmicity may be dependent on the time of administration. 相似文献
102.
Role of oligosaccharides in the processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1. 总被引:20,自引:0,他引:20
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
R Pal G M Hoke M G Sarngadharan 《Proceedings of the National Academy of Sciences of the United States of America》1989,86(9):3384-3388
The processing and maturation of envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) were studied in infected cells treated with inhibitors of oligosaccharide processing. In MOLT-3 cells chronically infected with HIV-1 (strain HTLV-IIIB), tunicamycin severely inhibited the glycosylation of envelope proteins. Deoxynojirimycin, an inhibitor of glucosidase I in the rough endoplasmic reticulum, inhibited the proteolytic processing of gp160, whereas no such effect was noted with either deoxymannojirimycin or swainsonine, inhibitors of mannosidase I and II, respectively, in the Golgi complex. The processed gp120 and gp41 synthesized in the presence of deoxymannojirimycin were found to contain mannose-rich oligosaccharide cores as evidenced by their susceptibility to endoglycosidase H digestion. The formation of syncytia normally observed when CEM cells are cocultured with HIV-1-infected cells was markedly inhibited in the presence of deoxynojirimycin, but such inhibition was not observed in cells treated with deoxymannojirimycin or swainsonine. The infectivity of virions released from MOLT-3/HTLV-IIIB cells treated with deoxynojirimycin or deoxymannojirimycin was significantly lower than the infectivity of virions released from untreated cells. On the other hand, treatment with swainsonine did not affect the infectivity of the progeny virus. These results suggest that the proteolytic processing of gp160 takes place in infected cells when the glycoprotein has mannose-rich oligosaccharide structures. Trimming of glucose residues and the primary trimming of mannose residues are necessary for the release of infectious virus. 相似文献
103.
SETTING: Serum amyloid P-component (SAP) plays important roles in host defense during various infectious diseases; however, nothing is known in tuberculosis (TB). OBJECTIVE: To study the SAP response of Mycobacterium tuberculosis H37Rv- and H37Ra-infected mice, and to determine the effect(s) of purified mouse SAP both on their intra-alveolar macrophage (AM) uptake and intra-AM growth in vitro. DESIGN: The SAP levels of mice intratracheally infected with M. tuberculosis H37Rv and H37Ra were determined by ELISA. Mycobacterial AM uptake and intra-AM growth in vitro were determined using fluorescence microscopy and plating, respectively. RESULTS: M. tuberculosis H37Rv-infected mice showed significantly (p < 0.05) increased SAP levels (352.8+/-36.1 microg/ml) with compared mice infected with M. tuberculosis H37Ra (170+/-18.5 microg/ml). During the acute phase of both these infections, enhanced SAP levels correlated with the lung mycobacterial load. In vitro, purified mouse SAP (1-80 microg/ml) inhibited the AM uptake of both the mycobacteria in a concentration-dependent manners to a similar extent; 20 microg/ml SAP appeared optimal. Mycobacterial uptake inhibition was divalent cation- and pH-dependent, and was unaffected both by heat-inactivated and deglycosylated SAP, separately. Curiously, purified mouse SAP (1-80 microg/ml), in a concentration-dependent manner, inhibited the intra-AM growth of both M. tuberculosis H37Rv and H37Ra in vitro; the effect was 0.8 log10 CFUs greater on the latter. Both the mannose-based simple sugars and rabbit anti-mouse SAP polyclonal antibody, separately, annulled the inhibition of mycobacterial growth in vitro. CONCLUSION: This initial study demonstrates that both the SAP response of M. tuberculosis-infected mice, and the SAP-induced intra-AM mycobacterial growth inhibition in vitro were apparently dependent on mycobacterial virulence. 相似文献
104.
Noninvasive transcutaneous low frequency ultrasound enhances thrombolysis in peripheral and coronary arteries 总被引:7,自引:0,他引:7
Siegel RJ Atar S Fishbein MC Brasch AV Peterson TM Nagai T Pal D Nishioka T Chae JS Birnbaum Y Zanelli C Luo H 《Echocardiography (Mount Kisco, N.Y.)》2001,18(3):247-257
Previous studies have shown that external ultrasound with low frequencies and high intensities can enhance thrombolytic drug-induced clot dissolution during in vitro experiments. In this series of studies, we evaluated the efficacy of peripheral and coronary thrombolysis in vivo in animals by using noninvasive transcutaneous ultrasound combined with thrombolytic drugs (streptokinase and tPA) and/or microbubbles agents (dodecafluoropentane [DDFP] and perfluorocarbon-exposed sonicated dextrose albumin [PESDA]). Thrombotic occlusions were induced in 74 rabbit iliofemoral arteries and 24 canine left anterior descending (LAD) coronary arteries in this in vivo study. By using the combination of transcutaneous ultrasound and streptokinase, the angiographic patency rate in rabbit iliofemoral arteries was higher (56%-100%) than with ultrasound (6%; P < or = 0.0036) and streptokinase alone (6%; P < or = 0.0012). Also, with transcutaneous ultrasound and microbubbles, the angiographic patency rates were 76%-100% as compared with ultrasound alone (0%, P < or = 0.0003) or microbubbles alone (9%, P < or = 0.0001). In the canine study of acute myocardial infarction, thrombolysis in myocardial infarction (TIMI) grade flow at 90 minutes in the tPA alone group was 0.92 +/- 1.4 as compared with 2.42 +/- 1.9 in the tPA plus transthoracic ultrasound group (P = 0.006). There was much improved reperfusion with tPA plus ultrasound as compared with tPA alone. In vivo animal studies demonstrate that noninvasive transcutaneous ultrasound can greatly enhance the effect of clot dissolution with thrombolytic drugs and/or microbubbles, and has the potential for clinical application as an adjunctive method to improve arterial thrombolysis. 相似文献
105.
106.
Saha Soma Pal Dey Poushali Mitra Souvik 《Proceedings of the National Academy of Sciences, India. Section B.》2021,91(4):919-927
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Microbial association is considered as a significant innovation for land colonization of mosses. Plagiomnium... 相似文献
107.
Shylla Lily Barik Saroj Kanta Joshi Santa Ram 《Proceedings of the National Academy of Sciences, India. Section B.》2021,91(4):799-810
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Bio-inoculants based on native Bacillus spp. have the potential to resuscitate the short... 相似文献
108.
The spread of highly pathogenic avian H5N1 influenza viruses since 1997 and their virulence for poultry and humans has raised concerns about their potential to cause an influenza pandemic. Vaccines offer the most viable means to combat a pandemic threat. However, it will be a challenge to produce, distribute and implement a new vaccine if a pandemic spreads rapidly. Therefore, efforts are being undertaken to develop pandemic vaccines that use less antigen and induce cross-protective and long-lasting responses, that can be administered as soon as a pandemic is declared or possibly even before, in order to prime the population and allow for a rapid and protective antibody response. In the last few years, several vaccine manufacturers have developed candidate pandemic and pre-pandemic vaccines, based on reverse genetics and have improved the immunogenicity by formulating these vaccines with different adjuvants. Some of the important and consistent observations from clinical studies with H5N1 vaccines are as follows: two doses of inactivated vaccine are generally necessary to elicit the level of immunity required to meet licensure criteria, less antigen can be used if an oil-in-water adjuvant is included, in general antibody titers decline rapidly but can be boosted with additional doses of vaccine and if high titers of antibody are elicited, cross-reactivity against other clades is observed. Prime-boost strategies elicit a more robust immune response. In this review, we discuss data from clinical trials with a variety of H5N1 influenza vaccines. We also describe studies conducted in animal models to explore the possibility of reassortment between pandemic live attenuated vaccine candidates and seasonal influenza viruses, since this is an important consideration for the use of live vaccines in a pandemic setting. 相似文献
109.
110.
Davide Abate Alda Saldan Carlo Mengoli Marta Fiscon Cristina Silvestre Loredana Fallico Marta Peracchi Lucrezia Furian Riccardo Cusinato Luciana Bonfante Barbara Rossi Francesco Marchini Dino Sgarabotto Paolo Rigotti Giorgio Palù 《Journal of clinical microbiology》2013,51(8):2501-2507
Assessing cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) represents an appealing strategy for identifying transplant recipients at risk of infection. In this study, we compared two gamma interferon-releasing assays (IGRAs), Quantiferon-CMV and CMV enzyme-linked immunosorbent spot (ELISPOT), to determine the ability of each test to predict protective CMV-specific T-cell responses. Two hundred twenty-one Quantiferon-CMV and ELISPOT tests were conducted on 120 adult kidney transplant recipients (KTRs), including 100 CMV-seropositive transplant recipients (R+) and 20 CMV-seronegative transplant recipients of a CMV-positive donor (D+/R−). As a control cohort, 39 healthy adult subjects (including 33 CMV-seropositive and 6 CMV-seronegative subjects) were enrolled. CMV IgG serology was used as a reference for both tests. In the CMV-seropositive individuals, the ELISPOT and Quantiferon-CMV assays provided 46% concordance with the serology, 12% discordance, 18% disagreement between ELISPOT or Quantiferon-CMV and the serology, and 24% gray areas when one or both tests resulted in weak positives. None of the CMV-seronegative subjects showed detectable responses in the ELISPOT or the Quantiferon-CMV test. In transplant recipients, both the ELISPOT and Quantiferon-CMV assays positively correlated with each other and negatively correlated with CMV DNAemia in a significant way (P < 0.05). During the antiviral prophylaxis, all 20 D+/R− KTRs we examined displayed undetectable Quantiferon-CMV and ELISPOT results, and there was no evidence of CMV seroconversion. The receiving operator curve (ROC) statistical analysis revealed similar specificities and sensitivities in predicting detectable viremia (areas under the curve [AUC], 0.66 and 0.62 for Quantiferon-CMV and ELISPOT, respectively). ELISPOT and Quantiferon-CMV values of >150 spots/200,000 peripheral blood mononuclear cells (PBMCs) and >1 to 6 IU gamma interferon (IFN-γ) were associated with protection from CMV infection (odds ratios [OR], 5 and 8.75, respectively). In transplant recipients, the two tests displayed similar abilities for predicting CMV infection. Both the ELISPOT and Quantiferon-CMV assays require several ameliorations to avoid false-negative results. 相似文献